跳至主要内容
临床试验/EUCTR2021-000440-22-BE
EUCTR2021-000440-22-BE进行中(未招募)1 期

Vaccination against COVID-19 in Pregnant and Lactating Women in Belgium - PREGCOVAC.BE

niversiteit Antwerpen0 个研究点目标入组 420 人开始时间: 2021年2月25日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
420

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Female population older than 18 years.
  • Ability to provide informed consent.
  • Being vaccinated with a COVID-19 vaccine.
  • Intend to be available for follow-up visits through one year
  • postvaccination.
  • Influenza and pertussis vaccination during pregnancy (as per Belgian
  • recommendations) is allowed.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 420
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Serious underlying immunological condition (e.g. immunosuppressive
  • disease or therapy, human immunodeficiency virus (HIV) infection…).
  • Systemic treatment with immune suppressive medication, including
  • chronic steroid use of > 10 mg prednisone or equivalent.
  • Anything in the opinion of the investigator that would prevent
  • volunteers from completing the study or put the volunteer at risk.

研究者

发起方
niversiteit Antwerpen

相似试验

Vaccination against COVID-19 in Pregnant and... | 临床试验